Neurotensin and neuromedin N undergo distinct proteolytic inactivation in ventral tegmental area and nucleus accumbens.
Checler
F
F
Institut de Pharmacologie Moléculaire et Cellulaire, UPR 411 CNRS, Valbonne, France.
Dauch
P
P
Masuo
Y
Y
Vincent
J P
JP
D000818:Animals; D009496:Neurotensin / Q000378:metabolism*; D009714:Nucleus Accumbens / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism*; D011480:Protease Inhibitors / Q000378:metabolism; D051381:Rats; D013681:Tegmentum Mesencephali / Q000378:metabolism*
D010446:Peptide Fragments; D011480:Protease Inhibitors; C042090:neuromedin N; D009496:Neurotensin